These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 15850327

  • 1. [A role of endothelin 1 in the pathogenesis of thromboangiitis obliterans (initital news)].
    Czarnacki M, Gacka M, Adamiec R.
    Przegl Lek; 2004; 61(12):1346-50. PubMed ID: 15850327
    [Abstract] [Full Text] [Related]

  • 2. [Selectins in the pathogenesis and diagnosis of early atherosclerotic changes in children and adolescents with risk factors (obesity, hypertension and diabetes)].
    Głowińska B, Urban M, Peczyńska J, Florys B.
    Przegl Lek; 2004; 61(9):935-9. PubMed ID: 15803902
    [Abstract] [Full Text] [Related]

  • 3. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA, Malatino LS, Santonocito M, Messina R, Attinà T, Dell'Arte S, Sarnataro F.
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W, Mastej K, Adamiec R.
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Endothelin-1 plasma concentration in children and adolescents with atherogenic risk factors.
    Głowińska B, Urban M, Hryniewicz A, Peczyńska J, Florys B, Al-Hwish M.
    Kardiol Pol; 2004 Oct; 61(10):329-38. PubMed ID: 15841114
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effectiveness of bosentan in the treatment of ischemic lesions in a case of thromboangiitis obliterans (Buerger disease): a case report.
    Palomo-Arellano A, Cervigón-González I, Torres-Iglesias LM.
    Dermatol Online J; 2011 Jul 15; 17(7):4. PubMed ID: 21810389
    [Abstract] [Full Text] [Related]

  • 15. Treatment of thromboangiitis obliterans (Buerger's disease) with high-potency vasodilators.
    Jiménez-Gallo D, Albarrán-Planelles C, Arjona-Aguilera C, Blanco-Sánchez G, Rodríguez-Mateos ME, Linares-Barrios M.
    Dermatol Ther; 2015 Jul 15; 28(3):135-9. PubMed ID: 25649782
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Analysis of L, E, and P selectins concentration in infants and young children with spastic bronchitis].
    Gasiorowska J, Czerwionka-Szaflarska M, Swincow G, Stefańska A, Odrowaz-Sypniewska G.
    Pol Merkur Lekarski; 2009 Mar 15; 26(153):184-7. PubMed ID: 19388529
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A, Ciolkiewicz M, Klimiuk PA, Sierakowski S.
    Scand J Rheumatol; 2009 Mar 15; 38(1):38-45. PubMed ID: 18991188
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.